A Phase Iii, Randomized, Multicenter, Open-Label Study Of Venetoclax Or Pomalidomide In Combination With Dexamethasone In Patients With T(11;14)-Positive Relapsed/Refractory Multiple Myeloma.
JOURNAL OF CLINICAL ONCOLOGY（2020）
关键词
multiple myeloma,venetoclax,dexamethasone,pomalidomide,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要